1. Home
  2. MD vs STOK Comparison

MD vs STOK Comparison

Compare MD & STOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pediatrix Medical Group Inc.

MD

Pediatrix Medical Group Inc.

HOLD

Current Price

$20.08

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Logo Stoke Therapeutics Inc.

STOK

Stoke Therapeutics Inc.

HOLD

Current Price

$34.65

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MD
STOK
Founded
1979
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Hospital/Nursing Management
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
2.0B
IPO Year
1996
2019

Fundamental Metrics

Financial Performance
Metric
MD
STOK
Price
$20.08
$34.65
Analyst Decision
Hold
Strong Buy
Analyst Count
4
10
Target Price
$20.00
$36.10
AVG Volume (30 Days)
843.2K
587.7K
Earning Date
05-20-2026
04-15-2026
Dividend Yield
N/A
N/A
EPS Growth
263.03
30.67
EPS
1.94
0.85
Revenue
$1,913,849,000.00
$36,555,000.00
Revenue This Year
$3.72
$428.68
Revenue Next Year
$2.62
N/A
P/E Ratio
$10.27
$40.59
Revenue Growth
N/A
316.34
52 Week Low
$11.84
$5.35
52 Week High
$24.99
$39.81

Technical Indicators

Market Signals
Indicator
MD
STOK
Relative Strength Index (RSI) 43.52 54.65
Support Level $16.41 $30.50
Resistance Level $22.47 $34.95
Average True Range (ATR) 0.85 2.24
MACD -0.03 0.09
Stochastic Oscillator 55.90 43.02

Price Performance

Historical Comparison
MD
STOK

About MD Pediatrix Medical Group Inc.

Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment which provides physician services including newborn, maternal-fetal, and other pediatric subspecialty care. It generates majority of the revenue through neonatology and other pediatric subspecialties.

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

Share on Social Networks: